home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Antibody Has Stranglehold On Tumours

  March, 26 2002 3:05
your information resource in human molecular genetics
A single antibody called herceptin can interfere with a malignant tumour's ability to maintain the blood vessels it needs to survive. It could provide a simple alternative to combinations of antitumour drugs, according to a Brief Communiction in this week's Nature (Vol. 416, No. 6878, 21 Mar 2002).

Tumours secrete chemicals called angiogenesis factors that trick the body into re-routing blood vessels into them to deliver essential supplies. Drugs that block different angiogenesis factors are available, but tumours quickly become resistant to them as there are a host of other factors they can use instead. As a result there is an urgent need for mixed cocktails of anti-angiogenesis drugs.

Herceptin is already used to treat some breast cancers. It blocks a receptor crucial to the survival of about 30% of these tumours. Rakesh Jain and colleagues at Harvard Medical School in Boston, Massachusetts, found that in doing so, herceptin also reduces production of angiogenic factors and stimulates the release of natural anti-angiogenic factors.

Breast cancer tumours in mice treated with herceptin had blood supply networks that resembled normal tissue and grew far more slowly than normal tumours as a result. The authors suggest that herceptin, or drugs like it, could eventually be used instead of complicated anti-angiogenic drug cocktails for treating breast cancers.

Rakesh Jain
tel +1 617 726 4083
e-mail jain@steele.mgh.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.